 |
|
|
| |
When Aesica was founded in 2004, we set out to bring something new to pharmaceutical manufacturing - an innovative, flexible and service-driven supplier of APIs, formulated products and custom synthesis solutions.
Since then, we've more than trebled in size and have gone from having a single site in the North East of England to being a significant global player with three sites in the UK and an international customer base.
Our pride in our North East heritage is clear in our choice of name - one of the forts at Chesters on Hadrian's Wall. At its foundation, Aesica had the global outlook and customer base that continues today.
Aesica Timeline: years of experience in the pharmaceutical and biotechnology industries
September 2007
Aesica acquires secondary manufacturing facility from Abbott at Queenborough, Kent
August 2007
Aesica opens new Pilot Plant at Cramlington site
October 2006
Aesica acquires chemical manufacturing facility from MSD at Ponders End, Enfield
2004-2006
Aesica established as the partner of choice for global pharmaceutical companies
September 2004
Aesica completed Management buyout from BASF
2003
Opening of the new Technical Centre
1995
BASF acquired Boots Pharmaceuticals
1987
Second manufacturing plant commissioned for development
1983
First manufacturing plant commissioned for development
1977
Cramlington site purchased by Boots Pharmaceuticals |
|
|
|
|
|
 |
|
 |
